Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease
Mark P. Chao(Stanford Medicine), Ravindra Majeti(Stanford University), Andrew J. Gentles(Stanford Medicine), Feng Lan(Chinese Academy of Medical Sciences & Peking Union Medical College), Rahul Sinha(Stanford University), Rachel M. Morganti(California Institute for Regenerative Medicine), Andreas Reinisch(Stem Cell Institute), Seethu Xavy(Stanford University), Joseph C. Wu(Cardiovascular Institute of the South), Soham Chanda(Colorado State University), Marius Wernig(Stanford University), Toshinobu Nishimura(Stanford University), Susmita Chatterjee(California Institute for Regenerative Medicine), Jinfeng Shen(California Institute for Regenerative Medicine), Mohamed Ameen(Illumina (United States)), M. Ryan Corces(Gladstone Institutes), Daniel Haag(California Institute for Regenerative Medicine), Haodi Wu(King University)
Cited by 131
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k